BEMIS Stock Quote

$42.03 arrow  Change: -0.61 %Chge: -1.43% Vol: 41,600
End Of Day Prices
High: 42.42 | Low: 42.03 | Open: 42.42 | Close: 42.03
52 Wk High: 49.29 | 52 Wk Low: 40.61 | Todays Pivot: 42.16
Sector: Basic Materials add stock to watch list

BMS Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Basic Materials Companies

Deltic Timber 87.72 red arrow 1,503
Intrepid Potash 33.15 green arrow 66,419
Clearwater Paper 50.35 green arrow 1,401
Newmont Mining 18.015 green arrow 513,375
Materion 50.9 green arrow 2,296
Reliance Steel & Aluminum 49.18 green arrow 70,450
Kaiser Aluminum Par $0.01 92.39 green arrow 7,842
Eastman Chem 107.62 green arrow 74,786

Above is a small selection of related companies to Bemis which compete alongside BMS within the Basic Materials sector. To see more related companies to BMS, view our stock market today information page.

Online News For Bemis

BMS, health monitors, self-stocking fridges… report visualises the home in 2050

The home of the future will generate and store enough surplus energy to charge an electric car, be run via a centralised building management system and incorporate “smart keys” that will give delivery and service firms controlled access. That’s ...


BMS’ elotuzumab / pomalidomide improves progression-free survival in cancer trial

Bristol-Myers Squibb (BMS) has announced that the ELOQUENT-3 trial, an international Phase 2 study evaluating the addition of Empliciti (elotuzumab) to pomalidomide and low-dose dexamethasone (EPd) in patients with relapsed/refractory multiple myeloma ...


Apexigen, BMS to combine CD40 and anti-CSF-1 drugs with Opdivo in new study

Apexigen has begun collaborating with Yale Cancer Center on an early-stage clinical trial that combines the biotech’s APX005M CD40 activator with Bristol-Myers Squibb’s Opdivo and cabiralizumab, an investigational anti-CSF-1 antibody, in patients with ...


BMS scholars excel

Megan Allgeier, Uriana Arthur, Jacqueline Aylor, Amos Bane, Evan Berkemeier, Taylor Blanton, Carter Bohman, Chloe Bohman, Ian Carpenter, Kennedy Cozart, Jada Day, Anna Deputy, Angela Diaz, Mason Doll, Quinton Elston, Toccoa Filice, Natasha Fowler, Lily ...


Bristol Myers Squibb : BMS scores China's first IO approval

China's State Drug Administration approved Opdivo nivolumab from Bristol-Myers Squibb Co. (NYSE:BMY), marking the country's first approval of an immuno-oncology agent, according to the pharma. The anti-PD-1 mAb is indicated to treat locally advanced or ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Bemis quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for BMS to choose from. Visit here to build your stock quote widget »